Dr. Aditya Mangla, DO

Dr. Mangla practices at Tjh Medical Services in Richmond Hill, New York.

Dr. Mangla's NPI, 1548453285, was assigned on August 27, 2007. Dr. Mangla holds New York license 245247-1.

Dr. Mangla's primary practice is Tjh Medical Services, at 134-20 Jamaica Ave, Richmond Hill, NY 11418 in Queens County. The practice phone is (718) 206-6742.

Dr. Mangla's primary practice is Tjh Medical Services in Richmond Hill, New York. Dr. Mangla is also affiliated with North Shore University Hospital. The medical group on file is Jamaica Hospital Medical Center. Dmand AI also links Dr. Mangla to 3 more hospitals, 4 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mangla practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Mangla's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Mangla is licensed in New York.

CMS data shows 203 Medicare services from Dr. Mangla across 7 procedure codes in 2024, for 123 Medicare patients. Medicare paid $22,899 for them.

CMS counts 123 Medicare patients who saw Dr. Mangla in 2024. The largest group is 65 to 74, with 46 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 50% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mangla's median patient age at 67, with 46% women.

In 2024, Dr. Mangla wrote 1,614 Medicare Part D claims for 231 patients. 86% of them were for generic drugs. CMS names the drug for 1,451 of them, across 25 drugs with 11 or more claims each, at $242,814 in total drug cost. In 2023, CMS named 1,302 claims across 25 drugs.

Dr. Mangla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 11 procedures of coronary angioplasty and stenting by Dr. Mangla, more than 30% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Mangla, published from 2015 to 2024. 2022 was the busiest year, with 3. The most frequent topics are Heart. Dr. Mangla has published most often in Cureus. Dr. Mangla's most frequent co-authors are Zoran Lasic, MD, Suresh P. Jain, MD and Zain Kassam, MD, MPH.

Dmand AI links Dr. Mangla to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Ischemia and Coronary Artery Disease.

CMS Open Payments shows 729 general payments to Dr. Mangla from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 48% of the total. Medtronic, Inc. paid the most, $17,835.